TY  - JOUR
T1  - Single-agent bevacizumab for the management of refractory malignant effusions in heavily pretreated patients with recurrent high-grade serous cancers of the ovary, fallopian tube or peritoneum: results from a single institution
A1  - Chay,W.Y.
A1  - Kumar,A.
A1  - Hoskins,P.J.
A1  - A.V.Tinke
JO  - European Journal of Gynaecological Oncology
VL  - 39
IS  - 6
SP  - 887
EP  - 880
SN  - 2709-0086
Y1  - 2018
ER  -